Patent · US Expired

Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use

US6596728B1 · kind B1 · utility

1Cited by

3References

4Claims

0Family size

Assignee

Aventis Pharma Deutschland GmbH · DE

Inventors

Reinhard Kirsch · Braunschweig, DE
Alfons Enhsen · Lennestadt, DE
Heiner Glombik · Hofheim, DE
Werner Kramer · Schwandorf, DE
Eugen Falk · Frankfurt am Main, DE

Key dates

Filing date	Oct 1, 1999
Grant date	Jul 22, 2003
Priority date	—
Expiry date	Oct 1, 2019

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Substituted 1,3-diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)propanol derivatives of the formula (I), and salts thereof, in which the radicals have the meanings given in the specification, and physiologically tolerated salts thereof and processes for their preparation are described. The compounds are suitable, for example, as hypolipidemic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.